3 Item1A. Risk Factors 12 Item 1B. Unresolved Staff Comments 58 Item 1 C . Cybersecurity 58 Item 2. Properties 59 Item 3. Legal Proceedings 59 Item 4. Mine Safety Disclosures 59 PARTII Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 60 Item 6. [Reserved] 62 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 62 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 74 Item 8....
Q2 FY2026 — expected 2026-08-08
| Type | Subject | Detail | Quarter |
|---|---|---|---|
| topic_mention | TXG | discussed Artificial Intelligence | Q4 FY2025 |
| topic_mention | TXG | discussed Blockchain & Crypto | Q4 FY2025 |
| topic_mention | TXG | discussed Supply Chain | Q4 FY2025 |
| topic_mention | TXG | discussed Regulation | Q4 FY2025 |
| topic_mention | TXG | discussed Automotive | Q4 FY2025 |
| topic_mention | TXG | discussed Healthcare & Bio | Q4 FY2025 |
| topic_mention | TXG | discussed Platform & Ecosystem | Q4 FY2025 |
| metric | TXG gross margin | reported $68 percent | Q4 FY2025 |
| metric | TXG gross margin | reported $69 percent | Q4 FY2025 |
| guidance | TXG | guided Guidance 10x Genomics expects full year 2026 revenue to be in the range of $600 million | Q4 FY2025 |
| topic_mention | TXG | discussed Artificial Intelligence | Q4 FY2025 |
| topic_mention | TXG | discussed Semiconductor | Q4 FY2025 |
| topic_mention | TXG | discussed Capital Expenditure | Q4 FY2025 |
| topic_mention | TXG | discussed Supply Chain | Q4 FY2025 |
| topic_mention | TXG | discussed Sovereign & Government | Q4 FY2025 |
| topic_mention | TXG | discussed Automotive | Q4 FY2025 |
| topic_mention | TXG | discussed Healthcare & Bio | Q4 FY2025 |
| topic_mention | TXG | discussed Platform & Ecosystem | Q4 FY2025 |
| metric | TXG gross margin | reported $68 percent | Q4 FY2025 |
| guidance | TXG | guided guidance range, and closed the year with $599 million | Q4 FY2025 |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-13 | 2025-12-31 | 0001628280-26-007822 | EDGAR | 80K words |
| 2025-02-13 | 2024-12-31 | 0001770787-25-000013 | EDGAR | — |
| 2024-02-15 | 2023-12-31 | 0001770787-24-000017 | EDGAR | — |
| 2023-02-16 | 2022-12-31 | 0001770787-23-000012 | EDGAR | — |
| 2022-02-18 | 2021-12-31 | 0001770787-22-000015 | EDGAR | — |
| 2021-02-26 | 2020-12-31 | 0001770787-21-000009 | EDGAR | — |
| 2020-02-27 | 2019-12-31 | 0001193125-20-052640 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-07 | 2026-06-30 | 0001628280-26-054491 | EDGAR | — |
| 2025-11-07 | 2025-09-30 | 0001628280-25-050332 | EDGAR | 16K words |
| 2025-08-08 | 2025-06-30 | 0001770787-25-000051 | EDGAR | — |
| 2025-05-09 | 2025-03-31 | 0001770787-25-000032 | EDGAR | — |
| 2024-10-29 | 2024-09-30 | 0001770787-24-000073 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0001770787-24-000060 | EDGAR | — |
| 2024-04-30 | 2024-03-31 | 0001770787-24-000036 | EDGAR | — |
| 2023-11-03 | 2023-09-30 | 0001770787-23-000053 | EDGAR | — |
| 2023-08-04 | 2023-06-30 | 0001770787-23-000047 | EDGAR | — |
| 2023-05-04 | 2023-03-31 | 0001770787-23-000029 | EDGAR | — |
| 2022-11-03 | 2022-09-30 | 0001770787-22-000057 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0001770787-22-000049 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-06 | 0001628280-26-054273 | EDGAR | — |
| 2026-02-12 | 0001628280-26-007673 | EDGAR | 3K words |
| 2026-01-12 | 0001628280-26-001808 | EDGAR | — |
| 2025-11-14 | 0001628280-25-052154 | EDGAR | — |
| 2025-11-06 | 0001770787-25-000058 | EDGAR | — |
| 2025-08-07 | 0001770787-25-000048 | EDGAR | — |
| 2025-06-05 | 0001770787-25-000040 | EDGAR | — |
| 2025-05-14 | 0001770787-25-000035 | EDGAR | — |
| 2025-05-08 | 0001770787-25-000031 | EDGAR | — |
| 2025-02-12 | 0001770787-25-000011 | EDGAR | — |
101 total filings indexed. 72 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| Call Date | Quarter | Title |
|---|---|---|
| — | Q4 FY2025 | TXG Q4 FY2025 Earnings Call Transcript |
| — | Q4 FY2025 | TXG Q4 FY2025 Earnings Call Transcript |
Access full transcripts via API (JSON) — includes speakers, key metrics, competitive mentions, and origin provenance chain.
| CIK | 0001770787 |
| Ticker | TXG |
| Exchange | Nasdaq |
| SIC | 3826: Laboratory Analytical Instruments |
| Incorporated | DE |
| Website | https://www.10xgenomics.com |
| Listed | 2019-09-12 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/TXG (~200 tokens, structured JSON with cryptographic provenance)